Reply by Authors
Urol Pract
.
2021 Mar;8(2):225.
doi: 10.1097/UPJ.0000000000000200.03.
Authors
Juan J Andino
1
,
Michael Sessine
2
,
Udit Singhal
1
,
Zachery R Reichert
3
,
Daniel Wray
4
,
Christine Shafer
1
,
Marissa Moore
1
,
Alon Z Weizer
1
,
Samuel D Kaffenberger
1
,
Lindsey A Herrel
1
,
Todd M Morgan
1
,
Khaled Z Hafez
1
,
Jeffrey S Montgomery
1
Affiliations
1
Department of Urology, Michigan Medicine; Ann Arbor, Michigan.
2
University of Michigan Medical School; Ann Arbor, Michigan.
3
Department of Internal Medicine, Division of Hematology and Oncology, Michigan Medicine; Ann Arbor, Michigan.
4
Twine Clinical Consulting, LLC; Park City, Utah.
PMID:
37064605
PMCID:
PMC10104477
DOI:
10.1097/UPJ.0000000000000200.03
No abstract available
Grants and funding
L30 CA264387/CA/NCI NIH HHS/United States